Manhattan, New York-based Global investment firm KKR announced a commitment of approximately $200 million to deepen its presence in India's rapidly growing medical devices industry. This investment is being channeled primarily through Healthium MedTech, KKR's India-based medical device platform, which it had acquired last year for roughly $840 million. Key...
KKR to Acquire Majority Stake in India’s Healthcare Global Enterprises
New York City-headquartered investment firm KKR, signed definitive agreements to become the largest shareholder and take control of Healthcare Global Enterprises (HCG) based in Bangalore, India. The transaction involves KKR acquiring up to 54% equity stake in HCG from Luxembourg-based CVC Capital Partners at a deal valued at $400 million...
Fosun Pharmaceutical Group Looks to Sell Stake in India’s Gland Pharma
Chinese billionaire Guo Guangchang’s Shanghai-based Fosun Pharmaceutical Group has approached several private equity firms to buy its stake in Hyderabd India-based Gland Pharma according to a report in Money Control Reportedly, Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR are among those who have been approached....
51 Indian Pharma Companies Get ANDA Approvals
Fifty-one of the 112 approvals for abbreviated new drug applications (ANDA) given by the USFDA went to India. Further, Indian companies received 6 tentative approvals from an aggregate of 23 tentative approvals in the Jan-March quarter of 2018. With eleven ANDA approvals, Aurobindo Pharma received the highest number among the...
Baxter Close to Acquiring Gland Pharma in India
Deerfield, IL-based Baxter, which specializes in parenteral nutrition and intravenous solutions is one of two companies that have bid for Hyderabad, India-based Gland Pharma, a contract manufacturer of generic injectables. Baxter is being represented by Citigroup. The other company in the running is the Shanghai Fosun Pharmaceutical (Group) Co. Ltd,...